# US 2025/0084454 A1 · Multiplexed immunosignal amplification using hybridization chain reaction-based method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084454 A1
- Document ID: US20250084454A1
- Status: Published application
- Kind: A1
- Application number: 18/958,038
- Filed: 2024-11-25
- Published: 2025-03-13
- Earliest claimed: 2020-07-23
- Assignees: GenAns Biotechnology Co., Ltd
- Applicants: GenAns Biotechnology Co., Ltd
- Inventors: Rui LIN; Minmin LUO
- Web page: https://patentgrep.com/patent/US20250084454A1

## CPC

- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6832: Enhancement of hybridisation reaction
- G01N 33/582: {with fluorescent label}
- G01N 33/6875: {Nucleoproteins}
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provides a method for optimizing isHCR for multiplexed labeling, which combines binder-biomolecule interactions with hybridization Chain Reaction (HCR).

## Claims

### Claim 1

A method for detecting multiple target biomolecules by using a kit, the kit comprising:
(1) orthogonal binders;
(2) orthogonal Hybridization Chain Reaction (HCR) initiators; and
(3) orthogonal pairs of HCR amplifiers, wherein each of HCR initiators has a region for hybridizing with a HCR amplifier, and a region for conjugating the orthogonal binders, and the orthogonal binders target multiple target biomolecules respectively to allow HCR amplification directed to multiple target biomolecules,
wherein the orthogonal binders are orthogonal antibodies, orthogonal single-domain antibodies (sdAbs), or fragments thereof,
wherein the orthogonal HCR initiators are directly conjugated to the orthogonal binders using click chemistry linkers which are selected from NHS-Azide linker, NHS-DBCO linker, maleimide-azide linker, and maleimide-DBCO linker, and
wherein the orthogonal HCR initiators are conjugated to the orthogonal binders by reacting DBCO-labeled HCR initiators with azide-activated binders, and
wherein the HCR amplifiers or the orthogonal pairs of HCR amplifiers are internally modified with a chemical group or a fluorescent dye, and the modification with a chemical group allows initiating further rounds of amplification.

### Claim 2 (depends on 1)

The method of claim 1, wherein the orthogonal antibodies are a collection of IgGs, the orthogonal sdAbs are a collection of sdAbs, and the fragments are a collection of scFvs.

### Claim 3 (depends on 1)

The method of claim 1, wherein the chemical group is selected from biotin, digoxigenin, acrydite, amine, succinimidyl ester, thiol, azide, TCO, Tetrazine, Alkyne, or DBCO, and the fluorescent dye is selected from Cyanine dyes, coumarin dyes, fluorescein dyes, and rhodamine dyes.

### Claim 4 (depends on 3)

The method of claim 3, wherein the pair of amplifiers comprise modification at internal positions, which are accessible to streptavidin and which serve as anchors for each successive round of branching in multi-round isHCR.

### Claim 5 (depends on 1)

The method of claim 1, wherein the kit further comprises grapheme oxide (GO).

### Claim 6 (depends on 5)

The method of claim 5, wherein GO has a particle size of <500 nm.
